Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study
Open Access
- 28 January 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 19765
Abstract
Compound infantile hemangiomas (IHs) are problematic and usually require intervention. This retrospective study aimed to introduce a combined therapy of oral propranolol and topical timolol and evaluate its efficacy and safety. Eighty-nine infants with compound IHs were treated with oral propranolol 2 mg/kg/day divided 2 times per day and timolol maleate 0.5% gel 3 times per day, for at least 3 months. Two observers evaluated the hemangioma independently at 0, 1, 3, 6, 9 months after the initiation of treatment. Changes in the hemangioma score values were evaluated using paired t test. Rebound growth and adverse effects were recorded. After treatment was completed, this combined therapy achieved clinical response in 100% of the patients (89/89). Significant positive effects were demonstrated at 1, 3, 6 months (p < 0.001), but not obvious after 6 months (p = 0.06). The response of IHs to the therapy was depending on the age at initial treatment. The average treatment duration was 6.48 (5.77–7.19) months. One patient (1.1%) relapsed after cessation of 6-month treatment and 7 children (7.8%) developed side effects. Our study suggested that oral propranolol combined with topical timolol treatment is very effective and well-tolerated for compound IHs, which can be used as a first line treatment.Keywords
This publication has 26 references indexed in Scilit:
- Propranolol versus Corticosteroids in the Treatment of Infantile HemangiomaPlastic and Reconstructive Surgery, 2013
- On Topical Timolol Gel‐Forming Solution for Infantile HemangiomasPediatric Dermatology, 2013
- Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus ConferencePediatrics, 2013
- A Prospective Study of Cutaneous Findings in Newborns in the United States: Correlation with Race, Ethnicity, and Gestational Status Using Updated Classification and NomenclatureThe Journal of Pediatrics, 2012
- Propranolol treatment of infantile hemangioma: clinical and radiologic evaluationsJournal of Pediatric Surgery, 2012
- A Controlled Study of Topical 0.25% Timolol Maleate Gel for the Treatment of Cutaneous Infantile Capillary HemangiomasOphthalmic Plastic & Reconstructive Surgery, 2012
- Propranolol Therapy in 55 Infants with Infantile Hemangioma: Dosage, Duration, Adverse Effects, and OutcomePediatric Dermatology, 2011
- A Randomized Controlled Trial of Propranolol for Infantile HemangiomasPediatrics, 2011
- Propranolol as first-line treatment for rapidly proliferating Infantile HaemangiomasJournal of Plastic, Reconstructive & Aesthetic Surgery, 2011
- Efficacy and safety of propranolol as first-line treatment for infantile hemangiomasEuropean Journal of Pediatrics, 2010